Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2013

Apr 2, 2013

30718_dirs_2013-04-02_d40132db-db88-499a-a090-8a997980ce16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-04-01

Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-04-01 Common Stock A 15000 Acquired 15000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-04-01 Stock Option $67.46 A 65000 Acquired 2020-04-01 Common Stock (65000) Direct
2013-04-01 Stock Option $67.46 A 50000 Acquired 2020-04-01 Common Stock (50000) Direct

Footnotes

F1: Vests 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017 and 1,361 shares on April 1, 2017.

F2: Vests pursuant to performance goals that will be determined by the Executive Compensation Committee of the Board of Directors of Techne Corporation within 60 days of April 1, 2013.